oxybutynin 10 mg
1 INDICATIONS AND USAGE Oxybutynin chloride extended-release tablets are a muscarinic antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency. Oxybutynin chloride extended-release tablets are also indicated for the treatment of pediatric patients aged 6 years and older with symptoms of detrusor overactivity associated with a neurological condition (e.g., spina bifida). • Oxybutynin chloride extended-release tablets are a muscarinic antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency. ( 1 ) • Oxybutynin chloride extended-release tablets are also indicated for the treatment of pediatric patients aged 6 years and older with symptoms of detrusor overactivity associated with a neurological condition (e.g., spina bifida). ( 1 )
Mylan Pharmaceuticals Inc.
ROUND ORANGE M O10
M O10 ROUND ORANGE
Related Pills
oxybutynin 5 mg
Mylan Pharmaceuticals Inc.
oxybutynin 5 mg
Mylan Pharmaceuticals Inc.
oxybutynin 10 mg
mylan pharmaceuticals inc.
oxybutynin 15 mg
mylan pharmaceuticals inc.
oxybutynin 5 mg
mylan pharmaceuticals inc.
oxybutynin 15 mg
mylan pharmaceuticals inc.
oxybutynin 10 mg
Mylan Pharmaceuticals Inc.
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING Oxybutynin Chloride Extended-Release Tablets, USP are available containing 5 mg, 10 mg or 15 mg of oxybutynin chloride, USP. The 5 mg tablets are light green, film-coated, round, unscored tablets with M over O 5 imprinted in black ink on one side of the tablet and blank on the other side. They are available as follows: NDC 0378-6605-01 bottles of 100 tablets NDC 0378-6605-05 bottles of 500 tablets The 10 mg tablets are peach, film-coated, round, unscored tablets with M over O 10 imprinted in black ink on one side of the tablet and blank on the other side. They are available as follows: NDC 0378-6610-01 bottles of 100 tablets NDC 0378-6610-05 bottles of 500 tablets The 15 mg tablets are white, film-coated, round, unscored tablets with M over O 15 imprinted in black ink on one side of the tablet and blank on the other side. They are available as follows: NDC 0378-6615-01 bottles of 100 tablets Storage: Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.] Protect from moisture and humidity. Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure. Keep out of reach of children.
More pills like ROUND M O10